MusclePharm Corp (MSLP)

Sector:
CONSUMER STAPLES
Industry:
PERSONAL PRODUCTS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Employees:
56
4721 IRONTON STREET, DENVER, CO 80239
(800) 210-7369

N/A

Data derived from most recent annual or quarterly report
Market Cap 7.557 Million Shares Outstanding34.349 Million Avg 30-day Volume 11.596 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.12
Price to Revenue0.1468 Debt to Equity-0.6377 EBITDA-5.116 Million
Price to Book Value0.0 Operating Margin-23.319699999999997 Enterprise Value31.076 Million
Current Ratio0.246 EPS Growth-9.286 Quick Ratio0.204
1 Yr BETA -3.3527 52-week High/Low 0.0 / Profit Margin-38.5051
Operating Cash Flow Growth-1159.0763 Altman Z-Score-26.9786 Free Cash Flow to Firm -4.91 Million
View SEC Filings from MSLP instead.

View recent insider trading info

MusclePharm Corp YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding MSLP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MSLP BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 3: filed on 2022-06-22 by CHIN ERIC
  • 4: filed on 2022-03-31 by BLUNDELL MARK
  • 4: filed on 2021-08-17 by DREXLER RYAN CHARLES
  • 3: filed on 2021-06-11 by KARR PAUL W
  • 3: filed on 2021-01-29 by HELLER MICHAEL DAVID
  • 4/A: filed on 2019-11-08 by WHITE WINSTON SELECT ASSET FUND SERIES FUND MP-18, LLC
  • 4/A: filed on 2019-11-08 by WHITE WINSTON SELECT ASSET FUND SERIES FUND MP-18, LLC
  • 4: filed on 2019-10-01 by WHITE WINSTON SELECT ASSET FUND SERIES FUND MP-18, LLC
  • 4: filed on 2019-09-20 by DREXLER RYAN CHARLES
  • 4: filed on 2019-09-16 by BUSH WILLIAM JOHN

    • Events (8k)

  • 8-K: filed on 2022-06-22:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-06-14:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.02: Unregistered Sales of Equity Securities
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-09:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-17:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-05:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-11:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-12-29:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2021-11-16:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-02:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    CHIN ERIC CHIEF ACCOUNTING OFFICER

    • Officer
    		 0 2022-06-17 1

    WHITE WINSTON SELECT ASSET FUND SERIES FUND MP-18, LLC

    WHITE WINSTON SELECT ASSET FUNDS, LLC

    ENRIGHT TODD M.

    BLUNDELL MARK

    FEAGAN DONALD

    MAHONEY ROBERT P

    • 10% Owner
    		 3,021,529 2022-03-29 1

    KARR PAUL W

    • Director
    		 0 2021-06-01 0

    HELLER MICHAEL DAVID

    • Director
    		 0 2021-01-19 0

    DREXLER RYAN CHARLES CEO AND PRESIDENT

    • Officer
    • Director
    • 10% Owner
    		 0 2020-11-29 0

    WYNNEFIELD PARTNERS SMALL CAP VALUE LP I

    WYNNEFIELD PARTNERS SMALL CAP VALUE LP

    WYNNEFIELD SMALL CAP VALUE OFFSHORE FUND LTD

    WYNNEFIELD CAPITAL MANAGEMENT LLC

    WYNNEFIELD CAPITAL INC

    WYNNEFIELD CAPITAL, INC. PROFIT SHARING PLAN

    OBUS NELSON

    LANDES JOSHUA

    • 10% Owner
    		 1,936,305 2019-09-27 0

    BUSH WILLIAM JOHN

    		492,181 2019-07-01 0

    DESMOND JOHN J

    		587,357 2019-07-01 0

    AMEROP HOLDINGS, INC.

    WESSELL LEONARD P. III

    • 10% Owner
    		 No longer subject to file 2018-06-22 0

    AMEROP HOLDINGS, INC.

    • 10% Owner
    		 2,211,781 2017-05-11 0

    LYNCH PETER CHRISTOPHER CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2016-12-05 0

    DORON MICHAEL J

    • Director
    		 150,314 2016-07-16 0

    JENKINS STACEY Y

    • Director
    		 90,529 2016-07-16 0

    ESTALELLA RICHARD

    • Director
    		 379,049 2016-01-22 0

    THOMPSON NOEL

    • Director
    		 19,412 2016-01-22 0

    GREGORY CORY J

    • FORMER EXECUTIVE VP
    		 No longer subject to file 2015-11-06 0

    PYATT BRAD J CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 885,025 2015-10-05 0

    PRICE JOHN C CHIEF FINANCIAL OFFICER

    • Officer
    		 100,000 2015-04-28 0

    LUPO ANDREW J

    • Director
    		 19,677 2014-11-21 0

    GREENWELL JAMES J CHIEF OPERATING OFFICER

    • Officer
    		 162,172 2014-11-20 0

    PROSSER DONALD W CHIEF FINANCIAL OFFICER

    • Officer
    		 152,172 2014-11-14 0

    MACOSKO GREGORY

    • Director
    		 5,281 2014-11-14 0

    ROLLOCK SYDNEY R CHIEF MARKETING & SALES OFF

    • Officer
    		 89,505 2014-05-12 0

    MCCLORY DANIEL JOSEPH

    • Director
    		 17,290 2014-03-28 0

    BLUHER JOHN H

    • FORMER OFFICER
    		 No longer subject to file 2014-01-24 0

    DAVIS LEWIS GARY CHIEF FINANCIAL OFFICER

    • Officer
    		 222,678 2013-12-05 0

    GROUSSMAN MARK

    • Director
    		 7,500,000 2012-07-13 0

    DELUCA JEREMY R. CO-PRES. & CHIEF MKTG. OFC.

    • Officer
    • Director
    • 10% Owner
    		 148,682,972 2012-04-25 0

    WINGATE MICHAEL SHAWN CHIEF OPERATING OFFICER

    • Officer
    		 0 2010-06-30 0

    MEER LAWRENCE S CHIEF FINANCIAL OFFICER

    • Officer
    • Director
    		 0 2010-06-30 0

    ARMENTA LEONARD K JR

    • Director
    		 0 2010-04-02 0

    HUSS TODD EDWIN CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2010-02-18 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    MUSCLE PHARM CORP MSLP 2022-06-28 22:15:04 UTC 0.3398 1.2302 100000
    MUSCLE PHARM CORP MSLP 2022-06-28 21:45:03 UTC 0.3398 1.2302 100000
    MUSCLE PHARM CORP MSLP 2022-06-28 21:15:03 UTC 0.3398 1.2302 100000
    MUSCLE PHARM CORP MSLP 2022-06-28 20:45:03 UTC 0.3398 1.2302 100000
    MUSCLE PHARM CORP MSLP 2022-06-28 20:15:04 UTC 0.3398 1.2302 100000
    MUSCLE PHARM CORP MSLP 2022-06-28 19:45:03 UTC 0.3398 1.2302 100000
    MUSCLE PHARM CORP MSLP 2022-06-28 19:15:03 UTC 0.3398 1.2302 100000
    MUSCLE PHARM CORP MSLP 2022-06-28 18:45:03 UTC 0.3398 1.2302 100000
    MUSCLE PHARM CORP MSLP 2022-06-28 18:15:04 UTC 0.3398 1.2302 100000
    MUSCLE PHARM CORP MSLP 2022-06-28 17:45:03 UTC 0.3398 1.2302 100000
    MUSCLE PHARM CORP MSLP 2022-06-28 17:15:03 UTC 0.3398 1.2302 100000
    MUSCLE PHARM CORP MSLP 2022-06-28 16:45:06 UTC 0.3398 1.2302 100000
    MUSCLE PHARM CORP MSLP 2022-06-28 16:15:03 UTC 0.3398 1.2302 100000
    MUSCLE PHARM CORP MSLP 2022-06-28 15:45:03 UTC 0.3398 1.2302 100000
    MUSCLE PHARM CORP MSLP 2022-06-28 15:15:03 UTC 0.3398 1.2302 100000
    MUSCLE PHARM CORP MSLP 2022-06-28 14:45:03 UTC 0.3398 1.2302 100000
    MUSCLE PHARM CORP MSLP 2022-06-28 14:15:04 UTC 0.3398 1.2302 100000
    MUSCLE PHARM CORP MSLP 2022-06-28 13:45:03 UTC 0.3398 1.2302 100000
    MUSCLE PHARM CORP MSLP 2022-06-28 13:15:03 UTC 0.3398 1.2302 100000
    MUSCLE PHARM CORP MSLP 2022-06-28 12:45:03 UTC 0.3398 1.2302 100000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    Elevate your investments